Safety of Four Treatment Regimens in Early Rheumatoid Arthritis

    June 2017 in “ Poster presentations ”
    E Fedorenko, G. Lukina, YA Sigidin, Д. Е. Каратеев
    Image of study
    TLDR All four treatments for early rheumatoid arthritis had similar safety profiles.
    The study compared the safety of four treatment regimens in 141 patients with early rheumatoid arthritis over one year. The regimens included methotrexate (MTX), MTX plus prednisolone (MTX-P), MTX-P plus methylprednisolone (MTX-P-MP), and leflunomide (LEF). Side effects were similar across groups, with 9 patients in each group experiencing them. Six patients discontinued therapy due to side effects, most frequently in the LEF group. The MTX-P group had no therapy withdrawals. Overall, side effects were generally moderate or minimal, and the safety profile was consistent across all groups.
    Discuss this study in the Community →